[lou_lou]

Drug Delivery Systems, 2006
Introduction

Drug delivery has changed. We are now looking at ways of enhancing CNS delivery through nasal administration, the role nanotechnology can play in targeted drug delivery and more novel delivery systems, such as PEGylation platforms. These technological advances allow increased delivery to target sites, maximise drug absorption and extend drug action. By considering the commercial effects of new emerging technology now, you will increase viability of your products, business relationships and investments for the future. To do this you will no doubt have to answer questions such as, do I chose new technology or a proven approach? Should I reposition as a specialty pharma? At what stage do I apply drug delivery to development projects?

This 3-day event being held 7-9 November 2006, will highlight the successful real-life strategies for improving business development, increasing value from collaborative partnerships and achieving commercialisation in today’s market. Now in its third year visiongain’s Drug Delivery Systems conference will enable you with an understanding of novel delivery systems, emerging drug delivery technologies and different partnership models, preparing you for 2007 and beyond. Whether you are a solution provider, prospective partner or an investor, the 3rd Annual Drug Delivery Systems conference will address the topics you care about, and provide you with the answers you need to speed your decision making process.

By attending this conference you will:

Examine ways to de-risk when delivery technology is applied in early development
Analyse how to smoothly transfer from research to development by pre-formulation and analytical support
Consider how to find the appropriate device development partner
Gain an understanding of how to effectively apply emerging technologies to your products
Evaluate how to prepare to evolve from a drug delivery to a specialty pharma company and forming new partnerships with big pharma
Explore practical methods for pre-clinical assessment of the efficacy, toxicity and mechanism of action of selected polymers
POST-CONFERENCE INTERACTIVE WORKSHOP
Best practise in drug delivery partnerships - 07 November 2006
Led by: Steve Poile, Director Licensing & Alliances and Co-Founder, Bridgehead International Ltd.
Robert Fishleigh, Director Strategy & Planning, Bridgehead International Ltd.

AND FOR SOME BACKGROUND READING....

Whether you wish to attend the conference or not we are also pleased to announce the availability of the following features:

Product Lifecycle Management, 2006
Inhalable Drug Delivery
Biogenerics: Challenges and Promise
Maximizing Product Returns Through Reformulation
Drug Delivery in Central Nervous System Diseases
Drug Delivery in Cancer
Transdermal Drug Delivery
Injectable Drug Delivery: Probing the Route to Growth
Advanced Drug Delivery